Download Poster (705 KB)
- The primary objective of this study was to determine if patients maintain viral suppression after switching from TDF to TAF
- The secondary objective was to assess changes in renal function and serum cholesterol levels
HIV, tenofovir, weight gain, cholesterol, cardiovascular disease
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
O'Connor, PharmD Candidate, Jaclyn; Sassa, PharmD, Kaitlin N.; and Schafer, PharmD, MPH, BCPS AQ-ID, BCIDP, AAHIVP, Jason J., "A Real World Assessment of the Efficacy and Safety of Switching from TDF to TAF in Treatment Experienced Patients with HIV Infection" (2019). College of Pharmacy Posters. 19.